Moneycontrol
HomeNewsTrendsEntertainmentCOVID-19 impact: What Tenet will mean for multiplexes in India whenever they reopen
Trending Topics

COVID-19 impact: What Tenet will mean for multiplexes in India whenever they reopen

A lot is riding on Tenet’s release in India as Hollywood content will be the first new content to test waters for the cinema business around Diwali time.

August 30, 2020 / 13:02 IST
Story continues below Advertisement
(Image: Twitter)

Christopher Nolan’s Tenet has been one of the most-awaited film releases so much so that even actor Tom Cruise could not stop himself from going to the theatres to watch the film.

The Hollywood venture which rolled out in international markets in a phased manner since August 26 has so far raked in over $40 million from as many as 40 overseas markets. The film is yet to release in China where the expectations are higher for Tenet’s collections as the box office in China is showing strong signs of revival.

Story continues below Advertisement

Tenet is scheduled to release in China on September 4.

Tenet’s business in theatres in times of COVID-19 is Hollywood’s big box office test. And, the film’s business in the initial few days is showing that people are back to theatres.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show